❗️Представленный Федеральным медико-биологическим агентством России препарат от коронавируса "Мефлохин" легко переносится и обладает выраженным противокоронавирусным действием, заявила глава ФМБА Вероника Скворцова.
ФМБА готово передать в больницу в Коммунарке препарат от коронавируса "Мефлохин", добавила Скворцова
In 2013 the United States Food and Drug Administration added a boxed warning to the U.S. label of mefloquine regarding the potential for neuropsychiatric side effects that may persist even after discontinuing administration of the drug.[19][20] In 2013 the FDA stated "Neurologic side effects can occur at any time during drug use, and can last for months to years after the drug is stopped or can be permanent."[21] Neurologic effects include dizziness, loss of balance, seizures, and tinnitus. Psychiatric effects include nightmares, visual hallucinations, auditory hallucinations, anxiety, depression, unusual behavior, and suicidal ideations.
Central nervous system events requiring hospitalization occur in about one in 10,000 people taking mefloquine for malaria prevention, with milder events (e.g., dizziness, headache, insomnia, and vivid dreams) in up to 25%.[22] When some measure of subjective severity is applied to the rating of adverse events, about 11-17% of travelers are incapacitated to some degree